Running a Value Review When No Baseline Was Set

Without a baseline, a value review cannot responsibly become a claim that a program paid for itself. It can still be a useful account conversation if it identifies what evidence exists, who can approve access, and what can be assessed going forward.

Ask the finance lead what question they need answered, which data sources are available, and who owns those sources. Distinguish an observed workflow fact from a financial conclusion. If clinical workflow data sits in a system finance cannot access, bring the appropriate clinical analytics or service line owner into the discussion.

A finance lead may ask, “Can you prove the program paid for itself?” Reply: “I cannot make that conclusion without verified data the customer has approved and a defined measure. Let’s identify the available data, the clinical and finance owners, and the period they can validate. We can then agree what question the review can answer and what remains outside the current record.”

This approach gives the customer a credible recovery path. It may produce a future baseline, a limited assessment, or a decision to collect information differently. Each is more useful than an unsupported conclusion.

Prepare for the meeting by making a data map: question, measure, source system, owner, permission status, and limitation. Use it to keep the conversation specific when an executive asks for a broad value statement.